Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
December 19 2022 - 6:04AM
Edgar (US Regulatory)
UNITED STATES SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
December 16, 2022
Commission File Number: 001-36686
Forward Pharma A/S
Østergade 24A, 1st Floor
1100 Copenhagen K, Denmark
Indicate by check mark whether the registrant files or will file annual reports under cover
of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(7): ☐
Item 1. Notice of Delisting
On December 16, 2022, Forward Pharma A/S (the “Company”) received written notice
from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that Nasdaq believes that the Company is a "public
shell" pursuant to Listing Rule 5101, and that the continued listing of its securities is no longer warranted. The Company will not
appeal this determination. Therefore, the Company expects the trading of its American Depositary Shares on The Nasdaq Capital Market to
be suspended at the opening of business on December 28, 2022, and that Nasdaq will file a Form 25-NSE with the U.S. Securities and Exchange
Commission (the “SEC”), which will remove the Company’s securities from listing and registration on The Nasdaq Stock
Market. Additionally, the Company intends to file with the SEC a Form 15 requesting the suspension of the Company’s reporting obligations.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
FORWARD PHARMA A/S |
|
|
|
|
|
|
|
|
|
Date: December 19, 2022 |
By: |
/s/ Claus Bo Svendsen |
|
|
|
Name: Claus Bo Svendsen |
|
|
|
Title: Chief Executive Officer |
|
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Jul 2023 to Jul 2024